ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Chenyu Yuan

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5121567247. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Comparative study on PD-L1/ALK dual-targeted biomimetic exosomes by two preparation approaches in pancreatic cancer. Co-author DOI 10.1016/j.ijbiomac.2026.152566 ↗
ANP32E expression in pancreatic cancer is associated with impaired gemcitabine efficacy and poor patient prognosis. Co-author DOI 10.1016/j.mcp.2025.102030 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Liang Li · 1 shared paper, 2026 · strength 0.30
- Paper Comparative study on PD-L1/ALK dual-targeted biomimetic exosomes by two preparation approaches in pancreatic cancer. DOI 10.1016/j.ijbiomac.2026.152566 ↗
Hong-Juan Yao · 1 shared paper, 2025 · strength 0.20
- Paper ANP32E expression in pancreatic cancer is associated with impaired gemcitabine efficacy and poor patient prognosis. DOI 10.1016/j.mcp.2025.102030 ↗
Qifeng Xiao · 1 shared paper, 2025 · strength 0.20
- Paper ANP32E expression in pancreatic cancer is associated with impaired gemcitabine efficacy and poor patient prognosis. DOI 10.1016/j.mcp.2025.102030 ↗
Yuchen Shi · 1 shared paper, 2025 · strength 0.20
- Paper ANP32E expression in pancreatic cancer is associated with impaired gemcitabine efficacy and poor patient prognosis. DOI 10.1016/j.mcp.2025.102030 ↗
Xiaohong Liu · 1 shared paper, 2025 · strength 0.20
- Paper ANP32E expression in pancreatic cancer is associated with impaired gemcitabine efficacy and poor patient prognosis. DOI 10.1016/j.mcp.2025.102030 ↗
Liang Li · 1 shared paper, 2025 · strength 0.20
- Paper ANP32E expression in pancreatic cancer is associated with impaired gemcitabine efficacy and poor patient prognosis. DOI 10.1016/j.mcp.2025.102030 ↗
Hebing Chen · 1 shared paper, 2025 · strength 0.20
- Paper ANP32E expression in pancreatic cancer is associated with impaired gemcitabine efficacy and poor patient prognosis. DOI 10.1016/j.mcp.2025.102030 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.